Vadim R Cherednichenko
Overview
Explore the profile of Vadim R Cherednichenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
16
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kiseleva D, Kirichenko T, Markina Y, Cherednichenko V, Gugueva E, Markin A
Biomedicines
. 2024 Feb;
12(2).
PMID: 38398066
Myocardial edema is the excess accumulation of fluid in the myocardial interstitium or cardiac cells that develops due to changes in capillary permeability, loss of glycocalyx charge, imbalance in lymphatic...
2.
Markina Y, Markin A, Kirichenko T, Tolstik T, Cherednichenko V, Kiseleva D, et al.
Front Biosci (Schol Ed)
. 2024 Jan;
15(4):17.
PMID: 38163956
Background: Mitochondrial dysfunction is considered an important mechanism in the pathogenesis of various diseases. Therefore, mitochondria are currently being considered as subjects for targeted therapies, particularly, phototherapy using 5-aminolevulinic acid....
3.
Markina Y, Kirichenko T, Tolstik T, Bogatyreva A, Zotova U, Cherednichenko V, et al.
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37373454
Cardiovascular diseases (CVD) and, in particular, atherosclerosis, remain the main cause of death in the world today. Unfortunately, in most cases, CVD therapy begins after the onset of clinical symptoms...
4.
Gureev A, Khorolskaya V, Sadovnikova I, Shaforostova E, Cherednichenko V, Burakova I, et al.
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36499517
In this research, we compared the cognitive parameters of 2-, 7-, and 15-month-old mice, changes in mitochondrial DNA (mtDNA) integrity and expression of genes involved in the nuclear erythroid 2-related...
5.
Gureev A, Shaforostova E, Vitkalova I, Sadovnikova I, Kalinina Y, Cherednichenko V, et al.
Toxicol Appl Pharmacol
. 2020 May;
398:115031.
PMID: 32389661
Mildronate is a cardiac and neuroprotective drug that is widely used in some countries. By inhibiting carnitine biosynthesis, mildronate impairs the fatty acids transport into mitochondria, thereby decreasing the β-oxidation...